Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5

The Lancet Oncology

Volumn 17, Issue 7, 2016, Pages 896-906

  Trama, Annalisa ^a   Botta, Laura ^a   Foschi, Roberto ^a   Ferrari, Andrea ^a   Stiller, Charles ^b   Desandes, Emmanuel ^c,d   Maule, Milena Maria ^e   Merletti, Franco ^e   Gatta, Gemma ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; EWING SARCOMA; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; YOUNG ADULT; AGED; CANCER STAGING; CHILD; COMPARATIVE STUDY; EUROPE; FOLLOW UP; INFANT; MIDDLE AGED; MORTALITY; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84969916559     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)00162-5     Document Type: Article

References (31)

1. 1 Gatta, G, Zigon, G, Capocaccia, R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 45 (2009), 992–1005.
2. 2 Bleyer, A, O'Leary, M, Barr, R, Ries, LAG, (eds.) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute report No: 06–5767, 2006, US National Cancer Institute, Bethesda, MD.
3. 3 Ofran, Y, Rowe, JM, Acute myeloid leukemia in adolescents and young adults: challenging aspects. Acta Haematol 132 (2014), 292–297.
4. 4 Wood, WA, Lee, SJ, Malignant hematologic diseases in adolescents and young adults. Blood 117 (2011), 5803–5815.
5. 5 Wilhelm, M, Dirksen, U, Bielack, SS, et al. ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. Ann Oncol 25 (2014), 1500–1505.
6. 6 Ferrari, A, Bisogno, G, Meazza, C, et al. The challenge of access to care for soft tissue sarcomas bridging pediatric and adultage: the Italian pediatriconcology view. Expert Rev Anticancer Ther 12 (2012), 243–254.
7. 7 Bisogno, G, Compostella, A, Ferrari, A, et al. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee. Cancer 118 (2012), 821–827.
8. 8 Stark, D, Brugieres, L, Dirksen, U, et al. Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. Eur J Cancer Care 25 (2015), 419–427.
9. 9 Barr, R, Eden, T, International working group on adolescent/teenage and young adult oncology. Pediatr Blood Cancer, 50(suppl 5), 2008, 1089.
10. 10 US Department of Health And Human Services US National Institutes of Health US National Cancer Institute, Adolescent and Young Adult Oncology Progress Report Group. Closing the gap: research and care imperatives for adolescents and young adults with cancers. http://www.cancer.gov/types/aya/research/ayao-august-2006.pdf, 2006 (accessed Dec 19, 2015).
11. 11 EUROCARE-5. Conclusions of the MAC roundtable “Key determinants of inequalities in cancer survival across Europe” (EP, 05 12. 2013). http://www.eurocare.it/Eurocare5/tabid/64/Default.aspx (accessed Dec 19, 2015).
12. 12 Fritz, A, Percy, C, Jack, A, et al. (eds.) International Classification of Diseases for Oncology (ICD-O), 3rd edn., 2000, World Health Organization, Geneva.
13. 13 De Angelis, R, Sant, M, Coleman, MP, et al., the EUROCARE-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population based study. Lancet Oncol 15 (2014), 23–34.
14. 14 Gatta, G, Botta, L, Rossi, S, et al., the EUROCARE Working Group. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15 (2014), 35–47.
15. 15 Steliarova-Foucher, E, Stiller, C, Lacour, B, Kaatsch, P, International classification of childhood cancer, third edn. Cancer 103 (2005), 1457–1467.
16. 16 Ederer, F, Axtell, LM, Cutler, SJ, The relative survival: a statistical methodology. Natl Cancer Inst Monogr 6 (1961), 101–121.
17. 17 Brenner, H, Söderman, B, Hakulinen, T, Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 31 (2002), 456–462.
18. 18 Brenner, H, Gefeller, O, An alternative approach to monitoring cancer patient survival. Cancer 78 (1996), 2004–2010.
19. 19 Cronin, K, Mariotto, A, Scoppa, S, Green, D, Clegg, L, Differences between Brenner et al and NCI methods for calculating period survival. Statistical Research and Applications Branch, NCI; Technical Report #2003–02-A. http://srab.cancer.gov/reports (accessed Dec 19, 2015).
20. 20 de Bont, JM, Holt, Bv, Dekker, AW, van der Does-van den Berg, A, Sonneveld, P, Pieters, R, Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 18 (2004), 2032–2035.
21. 21 Hallböök, H, Gustafsson, G, Smedmyr, B, et al. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer 107 (2006), 1551–1561.
22. 22 Ramanujachar, R, Richards, S, Hann, I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 48 (2007), 254–261.
23. 23 Stock, W, La, M, Sanford, B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 112 (2008), 1646–1654.
24. 24 Secker-Walker, LM, Prentice, HG, Durrant, J, Richards, S, Hall, E, Harrison, G, Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 96 (1997), 601–610.
25. 25 Ram, R, Wolach, O, Vidal, L, Gafter-Gvili, A, Shpilberg, O, Raanani, P, Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimes: systemic review and meta-analysis. Am J Hematol 87 (2012), 472–478.
26. 26 Micheli, A, Ciampichini, R, Oberaigner, W, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 45 (2009), 1017–1027.
27. 27 Tricoli, JV, Seibel, NL, Blair, DG, Albritton, K, Hayes-Lattin, B, Unique characteristics of adolescents and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst 103 (2011), 628–635.
28. 28 Bleyer, A, Barr, R, Hayes-Lattin, B, Thomas, D, Ellis, C, Anderson, B, The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8 (2008), 288–298.
29. 29 Lin, DW, Porter, M, Montgomery, B, Treatment and survival outcomes in young men diagnosed with prostate cancer: a population based cohort study. Cancer 115 (2009), 2863–2871.
30. 30 Salinas, CA, Tsodikov, A, Ishak-Howard, M, Cooney, KA, Prostate cancer in young men: an important clinical entity. Nat Rev Urol 11 (2014), 317–323.
31. 31 Birch, JM, Alston, RD, Kelsey, AM, Quinn, MJ, Babb, P, McNally, RJ, Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer 87 (2002), 1267–1274.